XML 38 R25.htm IDEA: XBRL DOCUMENT v3.5.0.2
Stock-Based Compensation (Tables)
6 Months Ended
Jul. 03, 2016
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Schedule of stock based compensation expense
The stock-based compensation expense included in the Company's consolidated financial statements for the three and six months ended July 3, 2016 and June 28, 2015 was as follows (in thousands):
 
 
Three Months Ended
 
Six Months Ended
 
July 3,
2016
 
June 28,
2015
 
July 3,
2016
 
June 28,
2015
Cost of revenue
$
47

 
$
27

 
$
85

 
$
66

Research and development
175

 
212

 
466

 
403

Selling, general and administrative
217

 
252

 
450

 
519

Total costs and expenses
$
439

 
$
491

 
$
1,001

 
$
988

Schedule of weighted average assumptions included in the estimated fair value calculations for stock option grants
The following weighted average assumptions are included in the estimated fair value calculations for stock option grants:

 
Three Months Ended
 
Six Months Ended
 
July 3,
2016
 
June 28,
2015
 
July 3,
2016
 
June 28,
2015
Expected term (years)
0

 
0

 
0

 
4.78

Risk-free interest rate
%
 
%
 
%
 
1.40
%
Expected volatility
%
 
%
 
%
 
52.11
%
Expected dividend yield

 

 

 

Summary of the activity in the shares available for grant under the 2009 plan
The following table summarizes the activity in the shares available for grant under the 2009 Plan during the six months ended July 3, 2016:
 
 
Shares
Available for Grant
 
(in thousands)
Balance at January 03, 2016
2,929

Options forfeited or expired
373

RSUs granted
(612
)
PRSUs granted
(193
)
RSUs forfeited or expired
159

PRSUs forfeited or expired
201

Balance at July 3, 2016
2,857

Summary of stock options outstanding and stock option activity under the 1999 plan and the 2009 plan, and the related weighted average exercise price
The following table summarizes stock options outstanding and stock option activity under the 1999 Plan and the 2009 Plan, and the related weighted average exercise price, for the first six months of 2016:
 
 
Number of Shares
 
Weighted
Average Exercise
Price
 
Weighted
Average
Remaining Term
 
Aggregate
Intrinsic Value
 
(in thousands)
 
 
 
(in years)
 
(in thousands)
Balance outstanding at January 3, 2016
5,266

 
$
2.64

 
 
 
 
Forfeited or expired
(373
)
 
$
2.74

 
 
 
 
Balance outstanding at July 3, 2016
4,893

 
$
2.63

 
3.82
 
$
17

Exercisable at July 3, 2016
4,542

 
$
2.62

 
3.50
 
$
17

Vested and expected to vest at July 3, 2016
4,838

 
$
2.63

 
3.77
 
$
17

Summary of activity for RSUs and PRSUs
A summary of activity for the Company's RSUs and PRSUs for the six months ended July 3, 2016 and information regarding RSUs and PRSUs outstanding and expected to vest as of July 3, 2016 is as follows:

 
RSUs & PRSUs Outstanding
 
Number of Shares
 
Weighted Average
Grant Date Fair Value
 
(in thousands)
 
 
Nonvested at January 3, 2016
1,435

 
$
2.30

Granted
805

 
1.11

Vested
(442
)
 
1.04

Forfeited
(360
)
 

Nonvested at July 3, 2016
1,438

 
$
2.08

Summary of the fair value of rights issued pursuant to ESPP
The fair value of rights issued pursuant to the Company's 2009 ESPP was estimated on the commencement date of each offering period using the following weighted average assumptions:
 
 
Three Months Ended
 
Six Months Ended
 
July 3,
2016
 
June 28,
2015
 
July 3,
2016
 
June 28,
2015
Expected term (months)
6.08

 
6.08

 
6.08

 
6.08

Risk-free interest rate
0.40
%
 
0.08
%
 
1.04
%
 
0.08
%
Volatility
54.31
%
 
51.54
%
 
61.06
%
 
51.54
%
Dividend yield